Development of nanoparticle-based magnetic resonance colonography

Magnetic Resonance in Medicine

Volumn 65, Issue 3, 2011, Pages 673-679

  Sun, Jihong ^a,b   Zheng, Weiliang ^c   Zhang, Hui ^c   Wu, Tao ^c   Yuan, Hong ^d   Yang, Xiaoming ^b,c   Zhang, Shizheng ^c  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c ZHEJIANG UNIVERSITY   (China)

^d ZHEJIANG UNIVERSITY   (China)

Author keywords

colonography; gadolinium diethylenetriaminepenta acetic acid (Gd DTPA); magnetic resonance (MR); solid lipid nanoparticles (SLNs)

Indexed keywords

ACETIC ACID; CYTOLOGY; DIAGNOSIS; EFFICIENCY; FLUORESCENCE; FLUORESCENCE MICROSCOPY; GADOLINIUM; MAMMALS; NANOMAGNETICS; NANOPARTICLES; PH; SIZE DISTRIBUTION; SYNTHESIS (CHEMICAL);

COLONOGRAPHY; ENTRAPMENT EFFICIENCY; FLUID ATTENUATED INVERSION RECOVERIES; FLUORESCEIN ISOTHIOCYANATE; GD-DTPA; PROOF OF PRINCIPLES; SOLID LIPID NANOPARTICLES; T1 RELAXATION TIME;

MAGNETIC RESONANCE;

ENEMA; FLUORESCEIN ISOTHIOCYANATE; GADOLINIUM; GADOLINIUM FLUORESCEIN ISOTHIOCYANATE SOLID LIPID NANOPARTICLE CONJUGATE; GADOLINIUM PENTETIC ACID CONJUGATE; GADOLINIUM SOLID LIPID NANOPARTICLE CONJUGATE; GREEN FLUORESCENT PROTEIN; OCTADECYLAMINE; PENTETIC ACID; SOLID LIPID NANOPARTICLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; COLON; COLORECTAL DISEASE; CONFOCAL MICROSCOPY; CONJUGATION; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FLUORESCENCE MICROSCOPY; HISTOPATHOLOGY; IN VIVO STUDY; MAGNETIC RESONANCE COLONOGRAPHY; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; RELAXATION TIME;

EID: 79951818100     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.22654     Document Type: Article

References (31)

1. Kung JW, Levine MS, Glick SN, Lakhani P, Rubesin SE, Laufer I,. Colorectal cancer: screening double-contrast barium enema examination in average-risk adults older than 50 years. Radiology 2006; 240: 725-735. (Pubitemid 44267328)
2. Gluecker TM, Johnson CD, Harmsen WS, Offord KP, Harris AM, Wilson LA, Ahlquist DA,. Colorectal cancer screening with CT colonography, colonoscopy, and double-contrast barium enema examination: prospective assessment of patient perceptions and preferences. Radiology 2003; 227: 378-384. (Pubitemid 36514750)
3. Hartmann D, Bassler B, Schilling D, Adamek HE, Jakobs R, Pfeifer B, Eickhoff A, Zindel C, Riemann JF, Layer G,. Colorectal polyps: detection with dark-lumen MR colonography versus conventional colonoscopy. Radiology 2006; 238: 143-149. (Pubitemid 43010590)
4. Runge VM, Stewart RG, Clanton JA, James AE, Partain CL,. Work in progress: potential oral and intravenous paramagnetic NMR contrast agents. Radiology 1983; 147: 789-791. (Pubitemid 13090114)
5. Nagata K, Singh AK, Sangwaiya MJ, Näppi J, Zalis ME, Cai W, Yoshida H,. Comparative evaluation of the fecal-tagging quality in CT colonography: barium vs. iodinated oral contrast agent. Acad Radiol 2009; 16: 1393-1399.
6. Ott DJ, Gelfand DW, Wu WC, Ablin DS,. Colon polyp morphology on double-contrast barium enema: its pathologic predictive value. Am J Roentgenol 1983; 141: 965-970. (Pubitemid 13021393)
7. Johansen JG,. Assessment of a non-ionic contrast medium (Amipaque) in the gastrointestinal tract. Invest Radiol 1978; 13: 523-527. (Pubitemid 9069195)
8. Laniado M, Kornmesser W, Hamm B, Clauss W, Weimann HJ, Felix R,. MR imaging of the gastrointestinal tract: value of Gd-DTPA. Am J Roentgenol 1988; 150: 817-821. (Pubitemid 18088256)
9. Ferrari M,. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 2005; 5: 161-171. (Pubitemid 40314948)
10. Couvreur P, Vauthier C,. Nanotechnology: intelligent design to treat complex disease. Pharm Res 2006; 23: 1417-1450. (Pubitemid 43993807)
11. Artemov D, Bhujwalla ZM, Bulte JW,. Magnetic resonance imaging of cell surface receptors using targeted contrast agents. Curr Pharm Biotechnol 2004; 5: 485-494. (Pubitemid 39654846)
12. Aime S, Cabella C, Colombatto S, Geninatti Crich S, Gianolio E, Maggioni F,. Insights into the use of paramagnetic Gd(III) complexes in MR-molecular imaging investigations. J Magn Reson Imaging 2002; 16: 394-406. (Pubitemid 35167875)
13. Weissleder R, Mahmood U,. Molecular imaging. Radiology 2001; 219: 316-333. (Pubitemid 32336342)
14. Yuan H, Chen J, Du YZ, Hu FQ, Zeng S, Zhao HL,. Studies on oral absorption of stearic acid SLN by a novel fluorometric method. Colloids Surf B Biointerfaces 2007; 58: 157-164. (Pubitemid 46921452)
15. Humberstone AJ, Charman WN,. Lipid-based vehicles for the oral delivery of poorly water soluble drugs. Adv Drug Deliv Rev 1997; 25: 103-128.
16. Morel S, Terreno E, Ugazio E, Aime S, Gasco MR,. NMR relaxometric investigations of solid lipid nanoparticles (SLN) containing gadolinium(III) complexes. Eur J Pharm Biopharm 1998; 45: 157-163. (Pubitemid 28167742)
17. Müller RH, Mäder K, Gohla S,. Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art. Eur J Pharm Biopharm 2000; 50: 161-177. (Pubitemid 30326695)
18. Pedersen N, Hansen S, Heydenreich AV, Kristensen HG, Poulsen HS,. Solid lipid nanoparticles can effectively bind DNA, streptavidin and biotinylated ligands. Eur J Pharm Biopharm 2006; 62: 155-162. (Pubitemid 43143267)
19. Yuan H, Huang LF, Du YZ, Ying XY, You J, Hu FQ, Zeng S,. Solid lipid nanoparticles prepared by solvent diffusion method in a nanoreactor system. Colloids Surf B Biointerfaces 2008; 61: 132-137.
20. de Bazelaire CM, Duhamel GD, Rofsky NM, Alsop DC,. MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results. Radiology 2004; 230: 652-659. (Pubitemid 38252858)
21. Mamisch TC, Dudda M, Hughes T, Burstein D, Kim YJ,. Comparison of delayed gadolinium enhanced MRI of cartilage (dGEMRIC) using inversion recovery and fast T1 mapping sequences. Magn Reson Med 2008; 60: 768-773.
22. Yang X,. Nano- and microparticle-based imaging of cardiovascular interventions: overview. Radiology 2007; 243: 340-347. (Pubitemid 46649688)
23. Desai MP, Labhasetwar V, Amidon GL, Levy RJ,. Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm Res 1996; 13: 1838-1845. (Pubitemid 27034116)
24. Damge C, Michel C, Aprahamian M, Couvreur P, Devissaguet JP,. Nanocapsules as carriers for oral peptide delivery. J Control Release 1990; 13: 233-239. (Pubitemid 20313521)
25. Sanders E, Ashworth CT,. A study of particulate intestinal absorption and hepatocellular uptake. Use of polystyrene latex particles. Exp Cell Res 1961; 22: 137-145.
26. Rinck PA,. Magnetic resonance in medicine. Oxford: Blackwell Scientific Publication; 2003.
27. Runge VM,. Safety of approved MR contrast media for intravenous injection. J Magn Reson Imaging 2000; 12: 205-213. (Pubitemid 30612863)
28. Caravan P, Ellison JJ, McMurry TJ, Lauffer RB,. Gadolinium (III) chelates as MRI contrast agents: Structure, Dynamics and Applications. Chem Rev 1999; 99: 2293-2352. (Pubitemid 30498114)
29. Weinmann HJ, Brasch RC, Press WR, Wesbey GE,. Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. Am J Roentgenol 1984; 142: 619-624. (Pubitemid 14199123)
30. Bargoni A, Cavalli R, Caputo O, Fundaro A, Gasco MR, Zara GP,. Solid lipid nanoparticles in lymph and plasma after duodenal administration to rats. Pharm Res 1998; 15: 745-750. (Pubitemid 28275652)
31. Chen HH, Le Visage C, Qiu B, Du X, Ouwerkerk R, Leong KW, Yang X,. MR imaging of biodegradable polymeric microparticles: a potential method of monitoring local drug delivery. Magn Reson Med 2005; 53: 614-620. (Pubitemid 40332282)